back to blog roll
Apr 6, 2020


  • Lessons from The Front Lines: COVID-19 by CMS
  • CMS Takes Action Nationwide to Aggressively Respond to Coronavirus National Emergency. See Facts Sheet.
  • In addition to CDC, many public health laboratories are now testing for the virus that causes COVID-19.
  • The number of cases is being actively monitored by the Centers for Disease Control and Prevention (CDC)
  • A study published on The New England Journal of Medicine describes the results of an analysis of the clinical characteristics of Covid-19 in a selected cohort of patients (n=1099) throughout China. In summary:
    • Out of the sample, 5.0% were admitted to the ICU, 2.3% underwent invasive mechanical ventilation, and 1.4% died.
    • The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). Lymphocytopenia was present in 83.2% of the patients on admission.
    • Studies reported different mortality rates, ranging from 1.4% to 15%. Chinese national official statistics reported a rate of death of 3.2% among 51,857 cases of Covid-19 as of February 16, 2020. Authors postulate that early isolation, early diagnosis, and early management might have collectively contributed to the reduction in mortality in Guangdong. 
  • The CDC provides the following recommendations for healthcare providers:
    • If you are a healthcare provider, be on the look-out for people who recently traveled from China and have fever and respiratory symptoms.
    • If you are a healthcare provider caring for a COVID-19 patient or a public health responder, please take care of yourself and follow recommended infection control procedures.

Coronavirus disease 2019 (COVID-19) Guidelines

Guidance for Facilities

COVID-19: New ICD-10-CM Code and Interim Coding Guidance

  • In response to the national emergency that was declared concerning the COVID-19 outbreak, a new diagnosis code, U07.1, COVID-19, has been implemented, effective April 1, 2020.
  • The CDC will implement a new diagnosis code into the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) for reporting, effective with the next update, October 1, 2020. Full addenda information regarding the new code and the final title will be presented at the March 2020 ICD10 Coordination and Maintenance Committee meeting. ICD-10-CM interim coding guidance can be found at: ( Meanwhile, the CDC provided interim coding guidance for exposure and confirmed cases of COVID-19 
  • For guidance on CMS reimbursement for diagnostic laboratory services, physician services (including telemedicine and telehealth), hospital services and drugs and vaccines under Medicare Part B, see CMS Covid-19 FAQ (3/9/20).
  • See Medicare Fee-for-Service (FFS) Response to the Public Health Emergency on the Coronavirus (COVID-19) published on 3/16/20

Handouts and Posters

Factsheet: What you need to know about coronavirus disease 2019 (COVID-19)  What you need to know about coronavirus disease (English/ Spanish/ Simplified Chinese)

Poster: Stop the spread of germs  Stop the spread of germs poster (English/ Spanish/ Simplified Chinese)


Explore our Wound Care and Hyperbaric Solutions